Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2014 Volume 10 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2014 Volume 10 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy

  • Authors:
    • Junxia Yao
    • Zunji Ke
    • Xiaoyan Wang
    • Feng Peng
    • Bin Li
    • Renliang Wu
  • View Affiliations / Copyright

    Affiliations: Institute of Pathology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Pathology, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China
    Copyright: © Yao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 39-44
    |
    Published online on: April 24, 2014
       https://doi.org/10.3892/mmr.2014.2179
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to examine the effects of epithelial‑mesenchymal transition (EMT) and apoptosis of renal tubular epithelial cells on the prognosis of immunoglobulin A (IgA) nephropathy. Renal biopsy tissues from 74 cases of IgA nephropathy were divided into a mild mesangial proliferation group (27 cases), a focal hyperplasia group (28 cases) and a proliferative sclerosis group (19 cases). The blood pressure, serum creatinine and 24 h urinary protein excretion of all patients were detected. To define EMT, α‑smooth muscle actin (α‑SMA), vimentin and collagen fibers were assessed. Apoptosis was determined by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). The blood pressure, serum creatinine and 24 h urinary protein excretion of patients with IgA nephropathy altered with increasing pathological grade. All clinical indices of patients in the proliferative sclerosis group were higher than those of the other two groups, and the 24 h urinary protein excretion of the focal hyperplasia group was statistically higher than that of the mild mesangial proliferation group. The expression of tubular interstitial α‑SMA, vimentin and collagen fibers increased with the pathological grade and was closely correlated with clinical indices, including collagen fibers and 24 h urinary protein excretion. TUNEL‑positive cells increased with the exacerbation of pathological changes. The EMT and apoptosis of renal tubular epithelial cells reflected the clinical severity of IgA nephropathy. α‑SMA, vimentin and the apoptotic index may be used as important markers for evaluating the prognosis of IgA nephropathy.

Introduction

Immunoglobulin A (IgA) nephropathy is also termed chronic glomerulonephritis and is characterized by deposits of IgA in the mesangial areas of the renal glomeruli and by recurring hematuria with only partial proteinuria. It occurs more commonly in young male adults. The clinical and pathological alterations of IgA nephropathy are diverse. Patient prognosis was initially considered to be good; however, several studies revealed that 10 years after the incidence of IgA nephropathy, 15–40% of patients enter the end-stage of renal failure (1,2).

Tubulointerstitial fibrosis is an important factor affecting the development and prognosis of IgA nephropathy (3). Previous studies have demonstrated that renal tubular epithelial-mesenchymal transition (EMT) was an important mechanism in tubulointerstitial fibrosis (4,5). When EMT occurs, renal tubular epithelial cells lose the characteristics of epithelial cells and the expression of α-SMA and vimentin, which is usually expressed in mesenchymal cells. The transformed cells are functionally similar myofibroblasts (MF), which synthesize the extracellular matrix (ECM) and contribute to the progressive development of renal interstitial fibrosis (6,7). Apoptosis of renal tubular cells is also known to contribute to the regulation of the renal cell number with an induction and repair of renal injury. The apoptosis of proximal tubular cells also occurs during renal tubular epithelial cell-mesenchymal transformation (8). EMT and apoptosis are major mechanisms of renal injury; however, there have been few studies investigating the effects of EMT and apoptosis of renal tubular epithelial cells on the prognosis of IgA nephropathy. In the present study, the renal biopsy sample tissues with IgA nephropathy were analyzed using immunohistochemical terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and Masson staining. The correlation between the transdifferentiation and apoptosis of renal tubular epithelial cells and clinical prognosis was analyzed.

Materials and methods

Samples and patients

In total, 74 renal biopsies with IgA nephropathy were selected, including 32 male cases and 42 female cases aged between 14 and 51 years (average age, 27.86±9.73 years), and cases with purpura nephritis, HBV-associated glomerulonephritis and lupus nephritis were excluded. The histological grading was based on Lee’s grading (9) and IgA nephropathy was further divided into the following groups: A, the mild mesangial proliferative group (Lee grade: level I–II, 27 cases); B, the focal hyperplasia group (Lee grade: level III, 28 cases); and C, the proliferative sclerosis group (Lee grade: level IV–V, 19 cases). Three normal renal tissue samples far from tumors on nephrectomy biopsies were selected as the control (9). All experiments were performed in the Laboratory of Medical Biomechanics, Hubei University of Medicine (Shiyan, China). The samples were pathologically confirmed by Taihe Hospital of Hubei, University of Medicine (Shiyan, China). The Institutional Ethics Committee of Hubei University of Medicine (Shiyan, China) approved the project and all the patients gave informed consent prior to participation.

Staining of collagen fibers

Collagen fibers in samples of renal needle biopsy and normal control samples were detected by Masson trichrome staining (Masson trichrome kit; Fuzhou Maixin Biotechnology Co., Ltd., Fuzhou, Fujian, China) with collagen fibers staining blue. Under the microscope, the ratio between renal interstitial areas with blue staining and total areas in the same visual field was calculated.

Immunohistochemical staining

The samples were fixed in 4% paraformaldehyde and embedded in paraffin. The sections were cut into 4-μm thick slices from paraffin blocks. Following deparaffinization and rehydration, the sections were boiled with citrate buffer for antigen retrieval. Following washing, they were immersed in 3% H2O2 in methanol to inhibit endogenous peroxidase. Anti-α-SMA and anti-vimentin (Fuzhou Maixin Biotechnology Co., Ltd.) were applied as primary antibodies. Phosphate-buffered saline (PBS) was used to replace the primary antibody in the negative controls and then the sections were incubated at 4°C overnight. The biotin-labeled secondary antibody and streptavidin-peroxidase were also added drop by drop, with diaminobenzidine (DAB) color development. All the reagents were purchased from Fuzhou Maixin Biotechnology Co., Ltd..

The Motic Med 6.0 pathological image analysis software from Beijing University of Aeronautics and Astronautics (Beijing, China) was selected to collect five visions (magnification, ×400) for each sample. The integrated optical density of tubulointerstitial α-SMA and vimentin-positive areas was examined and the average value was obtained.

Detection of apoptotic cells by TUNEL

The TUNEL kit purchased from Boehringer Mannheim GMBH (Mannheim, Germany) was used to label the apoptotic cells. The paraffin sections were processed by conventional dewaxing to water and the proteinase K (mass concentration of proteinase K was 20 mg/l and 10 mmol/l in Tris-HCl; pH 8.0) was then added for 15–25 min of digestion at 37°C. The sections were then washed in PBS and the methanol solution of H2O2 with the mass concentration of 3 g/l was used for sealing, which was followed by storing for 30 min at room temperature. Following this, the sections were washed in PBS, TUNEL reaction solution was added, the negative and positive controls were established and they were incubated for 30 min at 37°C. Then, the steps including washing in PBS, adding the conversion agent-POD and incubation for 30 min at 37°C were conducted. Following which, the sections were washed in PBS and DAB staining was performed for 3 min. In addition, distilled water was selected for washing and hematoxylin was selected for re-staining. Finally, dehydration, transparency processing and observation using a light microscope (BX51; Olympus Optical Co., Ltd. Tokyo, Japan) were performed. The cells with brown particles in the nucleus were the apoptotic cells.

Under a high-power microscope (magnification, ×400), five visions were randomly collected and analyzed by pathological image software (Motic Med 6.0; Beijing University of Aeronautics and Astronautics), and the positive cells were counted, with the average value of five visions as the index of cell apoptosis.

Statistical analysis

Data are shown as the mean ± standard error. The SPSS 13.0 software (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. Statistical analyses were performed using analysis of variance and linear trend. Individual comparisons were made using Fisher’s least significant difference. P<0.05 was considered to indicate a statistically significant difference.

Results

Clinical indicators

The blood pressure, serum creatinine and 24 h urinary protein excretion of patients with IgA nephropathy in three groups were analyzed. The clinical indices of the proliferative sclerosis group were significantly higher than those of the mild proliferation group and focal hyperplasia group (P<0.01). All clinical indices of the focal hyperplasia group were higher than those of the mild proliferation group, while the difference in 24 h urinary protein excretion between these two groups was statistically significant (P<0.01; Table I).

Table I

Clinical pathological features of immunoglobulin A nephropathy.

Table I

Clinical pathological features of immunoglobulin A nephropathy.

GroupCases (n)SBP (mm Hgc)DBP (mm Hg)Scr (μmol/l)Upro (g/24 h)
Mild mesangial proliferation (A)27117.85±14.8174.30±7.2970.70±13.210.49±0.60
Hyperplasia (B)28124.82±16.7477.93±10.2895.22±25.411.70±1.60a,b
Proliferative sclerosis (C)19141.74±31.67a,b94.47±19.37a,b150.11±109.80a,b2.86±1.65a,b

{ label (or @symbol) needed for fn[@id='tfn1-mmr-10-01-0039'] } Data are presented as the mean ± standard deviation.

a P<0.01, compared with A;

b P<0.01, compared with B;

c 1 mm Hg=0.133 kpa.

{ label (or @symbol) needed for fn[@id='tfn5-mmr-10-01-0039'] } SBP, systolic blood pressure; DBP, diastolic blood pressure; Scr, serum creatinine; Upro, urinary protein.

Pathological indices
Apoptosis

TUNEL-positive cells were distributed in tubules and the interstitium of IgA nephropathy tissue, with single, scattered or small cluster-like models, when those cells were rare in normal renal tissue (Fig. 1). The tubulointerstitial apoptotic index of IgA nephropathy in different pathological grades increased significantly (P<0.01; Table II).

Figure 1

(A) Apoptotic cell death in IgA nephropathy. TUNEL-positive cells occasionally appeared in normal renal tissue and TUNEL-positive cells occurred in tubules and interstitium of tissues with a (B) single and (C) scattered distribution in IgA nephropathy. Scale bar, 50 μm. TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; IgA; immunoglobulin A.

Table II

Tubulointerstitial cell apoptotic index and expression of α-SMA, vimentin and collagen fibers in immunoglobulin A nephropathy in different pathological grades.

Table II

Tubulointerstitial cell apoptotic index and expression of α-SMA, vimentin and collagen fibers in immunoglobulin A nephropathy in different pathological grades.

GroupCases (n)Apoptotic indexα-SMAVimentinCollagen fibers
Mild mesangial proliferation (A)2718.08±5.318.43±3.099.79±3.2512.51±3.46
Hyperplasia (B)2873.52±12.25a15.29±3.55a17.05±3.51a24.47±6.44a
Proliferative sclerosis (C)1948.79±11.06a,c13.13±3.66a,b19.50±4.13a,b31.16±6.43a,c

{ label (or @symbol) needed for fn[@id='tfn6-mmr-10-01-0039'] } Data are presented as the mean ± standard deviation.

a P<0.01, compared with A;

b P<0.05, compared with B;

c P<0.01.

{ label (or @symbol) needed for fn[@id='tfn10-mmr-10-01-0039'] } α-SMA, α-smooth muscle actin.

Expression and distribution of α-SMA

In normal renal tissue, α-SMA staining was positive only in vascular smooth muscle cells and not present in glomerular and tubulointerstitial cells. In IgA nephropathy, α-SMA expression was increased in renal tubular epithelial cells and renal interstitial cells (Fig. 2), and without changes in the glomerulus. Quantitatively, the expression of α-SMA increased in tubulointerstitial cells in hyperplasia and the proliferative sclerosis groups compared with that in the mild mesangial proliferation group (Table II).

Figure 2

Expression of α-SMA in IgA nephropathy. (A) α-SMA was only expressed in vascular smooth muscle cells in normal renal tissue. (B) Expression of α-SMA increased in renal tubular epithelial cells and renal interstitial cells (C) and renal tubular disorders occurred in the proliferative sclerosis group in IgA nephropathy. Scale bar, 50 μm. α-SMA, α-smooth muscle actin; IgA, immunoglobulin A.

Expression and distribution of vimentin

Vimentin was expressed in glomerular mesangial and certain renal interstitial cells of normal renal tissue; however, it was not expressed in renal tubular epithelial cells. In IgA nephropathy tissue, vimentin levels were higher in the glomerulus and expressed in renal tubular epithelial and interstitial cells (Fig. 3). Quantitative data demonstrated that the tubulointerstitial expression of vimentin was different in groups with different pathological grades (P<0.05 or P<0.01; Table II).

Figure 3

Expression of vimentin in IgA nephropathy. (A) Vimentin was expressed in glomerular mesangial cells and certain renal interstitial cells in normal renal tissue; however, the renal tubular epithelial cells and (B) vimentin-positive cells occurred in the glomerulus. (C) Expression increased in renal tubular epithelial cells and in renal interstitial cells in IgA nephropathy. Scale bar, 50 μm. IgA, immunoglobulin A.

Expression of collagen fibers

Masson staining showed collagen fibers in the renal interstitium. Interstitial collagen fibers increased in the renal interstitium of patients with IgA nephropathy with increasing pathological grading (Fig. 4). Quantitative data demonstrated that interstitial collagen fibers increased more in the proliferative sclerosis group than those in the mild proliferation group and the focal hyperplasia group (P<0.01), and those in the focal hyperplasia group were higher than those in the mild proliferation group (P<0.01; Table II).

Figure 4

Expression of collagen fibers. (A) Masson staining shows collagen fibers (blue) in the renal interstitium. (B and C) Expression of interstitial collagen fibers increased in the renal interstitium of immunoglobulin A nephropathy with pathological grading. Scale bar, 50 μm.

Relevance between the expression of vimentin, α-SMA and collagen fibers and serum creatinine and 24 h urinary protein excretion

Statistical analysis demonstrated that serum creatinine and 24 h urinary protein excretion was moderately correlated with the apoptotic index, expression of vimentin, α-SMA and collagen fibers (0.4≤r≤0.7; P<0.01; Table III).

Table III

Relevance between the expression of apoptotic indexes, vimentin, α-SMA and collagen fibers in immunoglobulin A nephropathy tissue (relevance coefficient r; n=74).

Table III

Relevance between the expression of apoptotic indexes, vimentin, α-SMA and collagen fibers in immunoglobulin A nephropathy tissue (relevance coefficient r; n=74).

IndecesApoptotic indexα-SMAVimentinCollagen fibers
Creatinine0.521a0.408a0.533a0.529a
Urinary protein0.457a0.466a0.548a0.574a

a P<0.01, pairwise comparison.

{ label (or @symbol) needed for fn[@id='tfn12-mmr-10-01-0039'] } α-SMA, α-smooth muscle actin.

Discussion

IgA nephropathy is a chronic renal disease and is the most common form of primary glomerular disease in the world, with ~20–40% of patients eventually entering into the end-stage of renal failure within 10–20 years (1–3,10). Currently, the most common clinical features of IgA nephropathy include blood pressure, serum creatinine and 24 h urinary protein excretion, which are closely correlated with histological grading; however, they are not associated with the renal prognosis (11,12). To further verify the association of blood pressure, serum creatinine and 24 h urinary protein excretion with the histological pathological alterations in patients with IgA nephropathy, previous studies grouped the patients according to the pathological diagnosis of renal biopsy tissue, which is different from the Oxford classification, by detailing the immunohistology of IgA nephropathy (13,14). The present study grouped the patients by a modification of Lee’s method, in which IgA nephropathy was further divided into the following groups: The mild mesangial proliferative group (Lee grade: level I–II), the focal hyperplasia group (Lee grade: level III) and the proliferative sclerosis group (Lee grade: level IV–V) (9). The results demonstrated that blood pressure, serum creatinine and 24 h urinary protein excretion of patients with IgA nephropathy worsened with increasing grade. Each clinical indicator of patients in the proliferative sclerosis group was significantly higher than that in the mild proliferation and local hyperplasia groups (P<0.01). In addition, 24 h urinary protein excretion of the focal hyperplasia group was significantly higher than that of the mild proliferation group (P<0.01). Collagen fibers, indicating the degree of fibrosis between different pathological grading, also ascended as the clinical stages gradually increased. Collagen fibers in the proliferative sclerosis group significantly deteriorated compared with those in the mild proliferation and local hyperplasia groups (P<0.01), and apparently increased in the focal hyperplasia group compared with the mild proliferation group (P<0.01). Serum creatinine and 24 h urinary protein excretion of patients were interrelated with the expression of collagen fibers (P<0.01). These results confirmed that the degree of interstitial fibrosis gradually worsened with the different pathological grading of IgA nephropathy, and proteinuria in patients increased, renal function weakened and the prognosis gradually deteriorated.

The main pathological symptoms of renal tubulointerstitial fibrosis include renal interstitial ECM accumulation, renal tubular atrophy and increased MFs in the renal interstitium. The pivotal step in renal interstitial fibrosis is the activation of fibroblasts, whose activated form is MFs. The quantity of collagen secreted by MFs is four- to five-fold higher compared with that secreted by fibroblasts, exacerbating ECM extracellular deposition and leading to renal structural remodeling due to its strong capacity to contract. Under pathological conditions, renal tubular epithelial cells possessed the capacity to transform into mesenchymal cells. In 1995, it was reported for the first time by Strutz et al (15) that EMT appears in renal fibrosis, followed by studies by Okada et al (16) and Fan et al (17), respectively, reporting that mice and rat renal tubular epithelial cells are able to transdifferentiate into MFs in experiments in vitro. Additionally, analysis of renal biopsies of 133 patients with different types of nephropathy revealed that the quantity of renal tubular epithelial cells with EMT characteristics was closely associated with the concentration of serum creatinine, as well as the degree of renal interstitial damage (18), suggesting that EMT is involved in the process of renal fibrosis (15). In the present study, it was observed that α-SMA and vimentin were expressed in renal tubular epithelial cells of IgA nephropathy renal biopsies. Among IgA nephropathy with different pathological grades, with the development of the disease, tubulointerstitial α-SMA and vimentin expression gradually increased (P<0.05 or P<0.01). This suggested that the phenotypic transformation indeed occurred in renal tubular epithelial cells of IgA nephropathy and, with the development of IgA nephropathy, transdifferentiation of tubule epithelial cells gradually increased. In addition, renal tubulointerstitial α-SMA and vimentin expression correlated with the expression of collagen fibers (P<0.01), and closely correlated with serum creatinine and 24 h urinary protein excretion of patients (P<0.01). These results lead to the conclusion that transdifferentiation of tubule epithelial cells is involved in the progression of the renal interstitial fibrosis lesion, relevant to the alterations in serum creatinine and 24 h urinary protein excretion of patients. Accordingly, it was verified that in IgA nephropathy, the transdifferentiation degree of renal tubular epithelial cells is associated with renal and tubulointerstitial fiber dysfunction, and the transdifferentiation of renal tubular epithelial cells may be one of the key factors leading to poor renal prognosis. Certainly, the detection of α-SMA and vimentin may be used as one of the clinical indicators in the assessment of IgA nephropathy prognosis.

Renal interstitial fibrosis lesions are usually paralleled with renal tubular atrophy, due to the involvement of renal tubular epithelial cells in the process of renal interstitial fibrosis through apoptosis. The present study showed that, in IgA nephropathy, apoptosis can be detected mainly in renal tubules and interstitium, particularly at sites where MFs have infiltrated, which is consistent with previous studies (16). It was also revealed that apoptosis in tissues increased with the development of the lesion. The apoptotic index was relatively low in the mild proliferation group and the highest in the focal hyperplasia group and decreased slightly in the proliferative sclerosis group (P<0.01). Therefore, it is hypothesized that at the early stages of lesions, the rate of apoptosis was relatively low, and as the lesion developed, apoptosis of tubule epithelial cells and interstitial cells increased. However, at the end-stage of lesions, the majority of tubule atrophy and the involvement of fibrosis in a relatively large area reduced the amount of apoptosis. Furthermore, it was also demonstrated that the apoptotic index of the tubulointerstitial region was moderately correlated with the degree of expression of interstitial MFs, fibrosis and clinical prognosis (P<0.01). In conclusion, tubulointerstitial cell apoptosis may be one of the factors leading to a poor prognosis in IgA nephropathy.

The present study demonstrated that α-SMA and vimentin expression of tubule epithelial cells, interstitial MF accumulation, collagen deposition, apoptosis of tubular epithelial and interstitial cells, interstitial fibrosis and renal dysfunction have a significant relevance in IgA nephropathy. Thus, it may be concluded that renal tubular epithelial cells in IgA nephropathy generate MFs through transdifferentiation, secreting a large quantity of collagen and finally leading to fibrosis, apoptosis of certain tubular epithelial cells, tubular atrophy and renal failure. Therefore, the transdifferentiation and apoptosis of renal tubular epithelial cells reflected the clinical severity of IgA nephropathy, and the detection of the expression of α-SMA, vimentin and apoptosis may be useful as an important index for evaluating the prognosis of IgA nephropathy.

References

1 

Berger J and Hinglais N: Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris). 74:694–695. 1968.(In French).

2 

Mubarak M: IgA nephropathy: an update on pathogenesis and classification. J Coll Physicians Surg Pak. 21:230–233. 2011.PubMed/NCBI

3 

Bogenschütz O, Bohle A, Batz C, et al: IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol. 10:137–147. 1990.PubMed/NCBI

4 

Liu Y: Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 69:213–217. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Zeisberg M and Kalluri R: The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl). 82:175–181. 2004. View Article : Google Scholar : PubMed/NCBI

6 

Chevalier RL: Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol. 2:157–168. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Hills CE and Squires PE: TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 31:68–74. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Pozdzik AA, Salmon IJ, Debelle FD, et al: Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 73:595–607. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Lee HS, Lee MS, Lee SM, et al: Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee’s glomerular grading system. Nephrol Dial Transplant. 20:342–348. 2005.PubMed/NCBI

10 

Glassock RJ: The pathogenesis of IgA nephropathy. Curr Opin Nephrol Hypertens. 20:153–160. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Li PK, Ho KK, Szeto CC, Yu L and Lai FM: Prognostic indicators of IgA nephropathy in the Chinese - clinical and pathological perspectives. Nephrol Dial Transplant. 17:64–69. 2002. View Article : Google Scholar : PubMed/NCBI

12 

Manno C, Strippoli GF, D’Altri C, Torres D, Rossini M and Schena FP: A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 49:763–775. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Bellur SS, Troyanov S, Cook HT and Roberts IS; Working Group of International IgA Nephropathy Network and Renal Pathology Society. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant. 26:2533–2536. 2011. View Article : Google Scholar

14 

D’Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 24:179–196. 2004.PubMed/NCBI

15 

Strutz F, Okada H, Lo CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 130:393–405. 1995. View Article : Google Scholar : PubMed/NCBI

16 

Okada H, Danoff TM, Kalluri R and Neilson EG: Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol. 273:F563–F274. 1997.PubMed/NCBI

17 

Fan JM, Ng YY, Hill PA, et al: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 56:1455–1467. 1999. View Article : Google Scholar : PubMed/NCBI

18 

Rastaldi MP, Ferrario F, Giardino L, et al: Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 62:137–146. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yao J, Ke Z, Wang X, Peng F, Li B and Wu R: Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy. Mol Med Rep 10: 39-44, 2014.
APA
Yao, J., Ke, Z., Wang, X., Peng, F., Li, B., & Wu, R. (2014). Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy. Molecular Medicine Reports, 10, 39-44. https://doi.org/10.3892/mmr.2014.2179
MLA
Yao, J., Ke, Z., Wang, X., Peng, F., Li, B., Wu, R."Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy". Molecular Medicine Reports 10.1 (2014): 39-44.
Chicago
Yao, J., Ke, Z., Wang, X., Peng, F., Li, B., Wu, R."Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy". Molecular Medicine Reports 10, no. 1 (2014): 39-44. https://doi.org/10.3892/mmr.2014.2179
Copy and paste a formatted citation
x
Spandidos Publications style
Yao J, Ke Z, Wang X, Peng F, Li B and Wu R: Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy. Mol Med Rep 10: 39-44, 2014.
APA
Yao, J., Ke, Z., Wang, X., Peng, F., Li, B., & Wu, R. (2014). Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy. Molecular Medicine Reports, 10, 39-44. https://doi.org/10.3892/mmr.2014.2179
MLA
Yao, J., Ke, Z., Wang, X., Peng, F., Li, B., Wu, R."Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy". Molecular Medicine Reports 10.1 (2014): 39-44.
Chicago
Yao, J., Ke, Z., Wang, X., Peng, F., Li, B., Wu, R."Epithelial‑mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy". Molecular Medicine Reports 10, no. 1 (2014): 39-44. https://doi.org/10.3892/mmr.2014.2179
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team